Blood circulation promotion via multi-herbal synergy in TCM theory Overview
"Blood circulation promotion via multi-herbal synergy in TCM theory" is a traditional Chinese medicine therapeutic concept, not a single molecule, receptor, or gene. It refers to the use of multiple herbs—each with different mechanisms—to synergistically improve blood circulation, reduce blood stasis (obstruction/sluggishness of blood), and treat related disorders such as cardiovascular diseases, diabetes complications, and vascular dysfunction. While mechanism studies have identified endpoints such as antiplatelet activity, vasorelaxation, endothelial protection, and Na⁺/K⁺-ATPase inhibition, this therapeutic principle is not reducible to any one molecular target[1][3][4][5]. Rather, it encompasses a polypharmacological, system-level intervention characteristic of TCM formulations. This entry does not map to a canonical drug target and should be flagged as improper or non-specific for structured target data.
Mechanism of Action
Antiplatelet aggregation (e.g., inhibition of TXA₂/PGI₂ imbalance); Vasodilation; Protection of vascular endothelium and basement membrane; Inhibition of Na⁺/K⁺-ATPase (through steroid-like compounds); Modulation of calcium signaling in myocardium; Inhibition of advanced glycation end-product formation; Antioxidant and lipid-lowering effects
Biological Functions
Disease Associations
Safety Considerations
- Herb-drug interactions (e.g., additive antiplatelet effect)
- Bleeding risk when combined with anticoagulants
- Variability in herbal compound potency/quality
- Null (no molecule-specific or receptor-specific toxicities)
Interacting Drugs
Associated Biomarkers
| Biomarker |
|---|
| Platelet aggregation rate |
| TXB₂ (thromboxane B2) concentration |
| 6-keto-PGF1α (prostacyclin metabolite) concentration |
| Hemorheological markers (e.g., blood viscosity) |
| Null (no canonical drug target biomarker as for molecular receptors) |
Gosset